Appia Bio Names Cell Therapy Manufacturing Veteran Qi Wei, PhD as Senior Vice President of Technical Operations

LOS ANGELES: LOS ANGELES, May 19, 2021 /PRNewswire/ -- Appia Bio, Inc., an early stage biotechnology company developing engineered allogeneic cell therapies from hematopoietic stem cells (HSCs) for cancer patients, today announced the addition of Qi Wei, PhD as Senior Vice President and Head of Technical Operations. Dr. Wei brings...

Click to view original post